Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3595 participants.

Also called NCT05665608

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 3,595 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05665608
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Czechia, Denmark, France, Germany, Hungary, Israel, Martinique, Netherlands, Poland, Spain, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05665608. Randomized; no masking; primary purpose prevention. Start 2023-11-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
Acronym
PROFID EHRA
Condition
Sudden Cardiac Death
Intervention (Device)
Implantable cardioverter-defibrillator (ICD)
Intervention (Drug)
Optimal Medical Therapy (OMT)
Lead sponsor
Charite University, Berlin, Germany (class: other)

Record details

Record id
cardio:ct-nct05665608
Content hash
9158800a616831e525f923b60223562fb5e4746bf1e9b93a7ab6ea247e8fd064